Worcester Business Journal

wbjournal.com | May 10, 2021 | Worcester Business Journal 11 H E A L T H C A R E P O W E R 5 0 Congratulations to President David Fithian. We are grateful for your leadership, your vision, and your commitment to Clark University and to our city. Steve Kerrigan PRESIDENT & CEO EDWARD M. KENNEDY COMMUNITY HEALTH CENTER, IN WORCESTER Residence: Lancaster College: The University of Maryland Kerrigan's career has taken him to some of the highest levels in the Democratic Party, having run both of President Barack Obama's inaugurations and as the CEO of the Democratic National Convention in 2012. But it was when Kerrigan, who was born in Worcester, returned home he met a new duty at the most critical of times. He took over at Kennedy less than a year before the facility, just like so many others working with high-risk populations, faced what could be its toughest challenge yet: the coronavirus pandemic. At the helm of the $35-million facility with 28,000 patients, Kerrigan provided clear leadership and ensured those vulnerable people with nowhere else to access health care had a place to go. What do you think the future holds for Central Mass.? "As our economy grows, bolstered by investments in infrastructure, our schools and more affordable housing, and transportation, we will solidify our true identity as an economic engine as well as a great place to live." A different path: "After college, I was going to join the Xaverian Brothers from Saint John's High School, and I was going to take the name Brother Aloysius. I still am proud of the relationship I have with the brothers, with Saint John's, and with the social justice missions they inspire, but I am also proud to be my husband's husband. Chalk that up as the road not traveled." Carolyn Langer, MD, JD, MPH SENIOR VICE PRESIDENT & CHIEF MEDICAL OFFICER FALLON HEALTH, IN WORCESTER Residence: Weston Colleges: University of Pennsylvania, Jefferson Medical College, Harvard University Langer has gone from her time in the military to a medical career with many of the biggest names in Massachusetts health care: Fallon Health today, and previously Harvard Pilgrim Health Care, Tufts Health Care, and Blue Cross Blue Shield of Massa- chusetts. Even before the coronavirus pandemic exposed the weaknesses in all these issues, Langer was a prominent voice on telehealth, health disparities, accessibility, and affordability. Langer, who has a son in his 20s with autism, bought the former Marian High School in Framingham last year with a nonprofit she formed, Invictus Forever, with plans to turn it into a place where those with disabilities can spend time when they're not at school or an adult day program. She serves on the board of the Health Foundation of Central Massachusetts, as board chair of the Meyers Primary Care Institute in Worcester and is a professor at UMass Medical School. What do you think the future holds for Central Mass.? "Cen- tral Massachusetts benefits from some of the most talented, innovative, and mission-driven people in the commonwealth. The level of collaboration among stakeholders has created a unique ecosystem." Colonel Langer, helicopter pilot: Langer is a retired colonel and army flight surgeon in the Army National Guard and accu- mulated about 100 hours flying helicopters. Stephen MacMillan CHAIRMAN, CEO & PRESIDENT HOLOGIC, IN MARLBOROUGH College: Davidson College, Harvard University As the head of a public company with more than 6,500 worldwide employees and more than $3.3 billion in annual revenue, MacMillan has held considerable power since he became CEO in 2013. That influence played out in new ways during the coronavirus pandemic, as Hologic was one of the first companies to develop a way to quickly do mass testings for COVID-19 infections in patients. Advanced types of testing was key to demystifying the disease in the early stages of the pandemic, as well as the effort to control its spread. Demand for products from Hologic's testing division led its revenues to rise more than 90% in the first quarter of 2021 alone, as the company became a bigger player in this space. Outside of Hologic's COVID efforts, MacMillan led the company has it undertook major acquisitions, such as San Diego cancer test company Biotheranostics for $230 million, German biopsy firm SOMATEX Medical Technologies GmbHfor $64 million, and Finnish-French testing and instrumentation company Mobidiag Oy for $795 million. The company continues to diversify its product offerings, a sign of the strength MacMillan has brought to Hologic, which had been struggling before his time as CEO.

• Cover